Clinical Trial Update: Intima Versus Adventitia Drug Delivery to Elucidate Mechanisms of Restenosis: Magnetic Resonance Imaging [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating intima versus adventitia drug delivery to elucidate restenosis mechanisms, monitored by MRI, has completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Peripheral Artery Disease

Snippet

Sponsor: University of California, San Francisco | Conditions: Peripheral Artery Disease, Vascular Disease | Phase 4 | Status: COMPLETED | Results posted: 2025-07-17